Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/

Diabetes Report Archive

Improving type 2 diabetes therapy adherence and persistence around the world.

 

Brazil

In Brazil, there are over 11.5 million people living with type 2 diabetes (T2D)—a figure expected to double by 2040. To date, there has been no coordinated, national initiatives to address the growing economic and societal burden of the condition, possibly as a result of the fragmentation and complexity of the Brazilian healthcare system. As such, there are significant opportunities to roll out T2D therapy compliance and persistence improvement solutions in both the public and private healthcare sectors.

 

Germany

In Germany, approximately 270,000 people are diagnosed with type 2 diabetes (T2D) annually and 8 million people are projected to live with the condition by 2030. The organisation of the German healthcare system promotes local rather than national initiatives when it comes to the management of the condition and the implementation of therapy adherence and persistence improvement solutions. These local initiatives could easily serve as scalable pilot projects that could be rolled out to other States.

 

Kingdom of Saudi Arabia

In Saudi Arabia, type 2 diabetes (T2D) prevalence is currently approximately 25% and the number of individuals suffering from the condition is forecasted to more than double by 2035. While the government is starting to recognize the growing burden of the condition, there remain opportunities to improve T2D therapy compliance and persistence, which include up-skilling primary-care HCPs and improving diabetes education.

 

Mexico

In Mexico, approximately 2 out of 5 people either have or are at high risk of developing type 2 diabetes (T2D). By 2040, 20.6 million people are projected to live with the condition in the country. The government and healthcare providers have started to recognize the growing economic and societal burden of the condition, which has resulted in a national strategy to prevent and control T2D and multidisciplinary care programs. These initiatives create opportunities to further improve therapy adherence and persistence by up-skilling of primary-care HCPs and promoting T2D education.

 

United Kingdom

In the U.K., policy makers and healthcare providers are starting to recognise and react to the societal and economic burden of type 2 diabetes (T2D). However, there are still opportunities to improve T2D therapy adherence and persistence, which drives a significant amount of this burden. In order to further promote T2D therapy adherence and persistence in the U.K., access to all forms of diabetes education could be increased while interactions between healthcare professionals and people with diabetes could be optimized.

 

United States

In the U.S., an estimated 400,000 seniors are diagnosed with type 2 diabetes (T2D) every year and 17.2 million seniors are expected to live with the condition by 2025. Recognizing the growing burden of T2D, policy makers and healthcare providers are already promoting adherence and persistence improvements in the Medicare population. However, there are further opportunities to tailor and integrate existing adherence and persistence improvement solutions into the lives of seniors living with the condition.

Contact Us